2024 annual financial data

Protara Therapeutics 2024 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -49.15M USD and net income was -44.6M USD.
Operating cash flow was -35.81M USD.

Get free Protara Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-49.15M USD
Net income
-44.6M USD
Operating cash flow
-35.81M USD